Skip to content
Open access

Pediatric Inpatient Continuous Glucose Monitor Accuracy by Sensor Wear Day, Hospital Day, and Glucose Rate of Change

Sep 2026 · Diabetes Technology & Therapeutics · pp. 15209156261486139 - 15209156261486139 · 0 citations · 43 references
Medicine

TL;DR

In this pediatric hospital CGM accuracy study, MARD was within a favorable range of <14% overall and throughout sensor wear and hospitalization, highlighting the need to incorporate trend arrows into hospital CGM protocols.

Abstract

Background: Continuous glucose monitoring (CGM) improves glycemic outcomes but inpatient use in the U.S. is not FDA approved, despite the potential need for frequent glycemic monitoring during hospitalization. We sought to assess CGM accuracy in the pediatric hospital setting and to evaluate the impact of potential modifiers of accuracy including sensor wear day, hospitalization day, and glucose changes. Methods: In this retrospective cross-sectional accuracy study among youth and young adults with diabetes hospitalized at two pediatric centers, reference point-of-care (POC) capillary glucose values were compared with Dexcom G7 CGM glucose readings (paired within 5 minutes). Accuracy was assessed using standard metrics including mean absolute relative difference (MARD) and Parkes Error Grids, overall, and stratified by sensor wear day, hospital day, and CGM glucose rate of change. Results: We analyzed 544 POC-CGM glucose pairs from 68 participants with diabetes aged 2–22 years (mean 12.4±5.8 years old, 58.8% female, 66.2% white, 8.8% Hispanic) during 80 hospital encounters. The overall MARD was 12.5%. Accuracy was comparable on sensor wear day 1 and days 2–6 (MARD 12.3% vs 13.6%, respectively) and was best on wear days 7–10 (MARD 10.6%). Accuracy improved from hospital day 1 (MARD 13.7%) to hospital days 2–4 and 5–30 (MARD 10.4% and 12.5%, respectively). Overall and on wear day 1, almost all glucose pairs (99%) fell within low-risk Parkes Error Grid zones A and B. Accuracy was best with a flat (−1 to 1 mg/dL/min) rate of change (MARD 11.5–11.9%) and was reduced with rapidly rising or falling (beyond −2 or 2 mg/dL/min) CGM values (MARD 16.6–18.4%). Conclusions: In this pediatric hospital CGM accuracy study, MARD was within a favorable range of <14% overall and throughout sensor wear and hospitalization. Reduced accuracy with rapidly changing glucose highlights the need to incorporate trend arrows into hospital CGM protocols.

Read PDF

Similar papers

Open access Oct 2026

Continuous glucose monitoring for diabetes mellitus in the perioperative and intensive care setting: a prospective observational validation study✰.

BACKGROUND In-hospital diabetes mellitus management currently relies on intermittent glucose monitoring with point-of-care (POC) testing, rather than continuous glucose monitoring (CGM). Most studies on CGM have focused on its benefits and accuracy in the outpatient setting, in contrast to the hospital setting, where t...

C. Pedersen, Aslak Johansen, A. Philipsen et al. · 0 citations
Oct 2026

Pediatric Inpatient Continuous Glucose Monitoring: Development and Implementation of a Hospital Policy for Accuracy-Validated Insulin Dosing.

An inpatient CGM policy from an adult to pediatric hospital setting is translated, supporting high levels of protocol adherence, clinical accuracy, safety, and improved experiences for clinicians.

Ming-Yeh Lee, Hector I. Ortega, Christopher Chow-Parmer et al. · 0 citations
Open access Sep 2026

Impact of Hybrid Continuous Glucose Monitoring on Glycemic Control in a Medical Intensive Care Unit.

In this prospective MICU cohort, real-time hybrid CGM use improved glycemic control and reduced severe hyperglycemia without increasing hypoglycemia, supporting further evaluation of structured CGM integration in critical care practice.

E. Faulds, Melanie Natasha Rayan, Molly McNett et al. · 1 citation
Open access Sep 2026

Analysis of glycemic trends in elderly patients with diabetes mellitus with continuous glucose monitoring

Background: Glycemic control is critical in elderly diabetics, considering their increased vulnerability to hypo- and hyperglycemic events. Continuous Glucose Monitoring (CGM) offers real-time, 24-hour insights into glucose fluctuations by measuring interstitial glucose levels over 14 days. CGM summarizes glycemic vari...

Anandita Gulhane, Mihir Awasarikar, S. Padole et al. · 0 citations
Review Sep 2026

Continuous glucose monitoring devices in hospitalized pediatric patients.

Continuous glucose monitoring (CGM) has revolutionized the landscape of diabetes management both in adults and pediatrics. CGM devices are now standard-of-care for pediatric diabetes management and are increasingly used in hospitalized patients. In the outpatient setting, studies show increasing analytical and clinical...

Isaiah K. Mensah, Christopher W. Farnsworth · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.